4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000078
Chief Executive Officer sold 15,884 shares at $14.51 ($230,431)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2025-07-11 | Sale 10b5-1 | −15,884 | $14.51 | $230,431 | 846,405 | D |
| Open-market sales · 15,884 sh · avg $14.51 · $230,431 | |||||||
Loading xslF345X05/wk-form4_1752613354.xml…